Suppr超能文献

细胞因子信号的微调。

Fine-Tuning Cytokine Signals.

机构信息

Laboratory of Molecular Immunology and the Immunology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892-1674, USA; email:

出版信息

Annu Rev Immunol. 2019 Apr 26;37:295-324. doi: 10.1146/annurev-immunol-042718-041447. Epub 2019 Jan 16.

Abstract

Cytokines are secreted or otherwise released polypeptide factors that exert autocrine and/or paracrine actions, with most cytokines acting in the immune and/or hematopoietic system. They are typically pleiotropic, controlling development, cell growth, survival, and/or differentiation. Correspondingly, cytokines are clinically important, and augmenting or attenuating cytokine signals can have deleterious or therapeutic effects. Besides physiological fine-tuning of cytokine signals, altering the nature or potency of the signal can be important in pathophysiological responses and can also provide novel therapeutic approaches. Here, we give an overview of cytokines, their signaling and actions, and the physiological mechanisms and pharmacologic strategies to fine-tune their actions. In particular, the differential utilization of STAT proteins by a single cytokine or by different cytokines and STAT dimerization versus tetramerization are physiological mechanisms of fine-tuning, whereas anticytokine and anticytokine receptor antibodies and cytokines with altered activities, including cytokine superagonists, partial agonists, and antagonists, represent new ways of fine-tuning cytokine signals.

摘要

细胞因子是分泌或其他方式释放的多肽因子,发挥自分泌和/或旁分泌作用,大多数细胞因子在免疫和/或造血系统中发挥作用。它们通常具有多效性,控制着发育、细胞生长、存活和/或分化。相应地,细胞因子具有重要的临床意义,增强或减弱细胞因子信号可能产生有害或治疗效果。除了细胞因子信号的生理微调外,改变信号的性质或效力在病理生理反应中也很重要,并且还可以提供新的治疗方法。在这里,我们概述了细胞因子及其信号转导和作用,以及生理机制和药理学策略来微调它们的作用。特别是,单个细胞因子或不同细胞因子对 STAT 蛋白的不同利用以及 STAT 二聚体与四聚体化是微调的生理机制,而抗细胞因子和抗细胞因子受体抗体以及具有改变活性的细胞因子,包括细胞因子超激动剂、部分激动剂和拮抗剂,则代表了微调细胞因子信号的新方法。

相似文献

1
Fine-Tuning Cytokine Signals.细胞因子信号的微调。
Annu Rev Immunol. 2019 Apr 26;37:295-324. doi: 10.1146/annurev-immunol-042718-041447. Epub 2019 Jan 16.
2
Making sense of IL-6 signalling cues in pathophysiology.解析病理生理学中的 IL-6 信号线索。
FEBS Lett. 2022 Mar;596(5):567-588. doi: 10.1002/1873-3468.14201. Epub 2021 Oct 15.
3
Interpreting mixed signals: the cell's cytokine conundrum.解读复杂信号:细胞细胞因子的难题。
Curr Opin Immunol. 2011 Oct;23(5):632-8. doi: 10.1016/j.coi.2011.07.013. Epub 2011 Aug 16.

引用本文的文献

本文引用的文献

1
Emerging Therapies for Inflammatory Bowel Disease.炎症性肠病的新兴治疗方法。
Adv Ther. 2018 Nov;35(11):1746-1762. doi: 10.1007/s12325-018-0795-9. Epub 2018 Oct 29.
4
An Update on JAK Inhibitors.JAK 抑制剂的最新进展
Curr Med Chem. 2019;26(10):1806-1832. doi: 10.2174/0929867325666180327093502.
5
CAR T cell immunotherapy for human cancer.嵌合抗原受体 T 细胞免疫疗法治疗人类癌症。
Science. 2018 Mar 23;359(6382):1361-1365. doi: 10.1126/science.aar6711.
9
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.针对癌症中的 IL-6/JAK/STAT3 信号通路。
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248. doi: 10.1038/nrclinonc.2018.8. Epub 2018 Feb 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验